{"prompt": "['prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet', 'Oncol. Nov 2008;9(11):1039-1047.', '21.', 'Lubik AA, Gunter JH, Hollier BG, et al. IGF2 increases de novo steroidogenesis in prostate cancer', 'cells. Endocrine-related cancer. Apr 2013;20(2): 173-186.', '22.', 'Ornish D, Lin J, Chan JM, et al. Effect of comprehensive lifestyle changes on telomerase activity and', 'telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive', 'pilot study. The lancet oncology. Oct 2013;14(11):1112-1120.', '23.', 'Platz EA, Till C, Goodman PJ, et al. Men with low serum cholesterol have a lower risk of high-grade', 'prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol', 'Biomarkers Prev. Nov 2009;18(11):2807-2813.', '24.', 'Platz EA, Clinton SK, Giovannucci E. Association between plasma cholesterol and prostate cancer in', 'the PSA era. Int J Cancer. Oct 1 2008; 123(7):1693-1698.', '25.', 'Magbanua MJ, Richman EL, Sosa EV, et al. Physical activity and prostate gene expression in men with', 'low-risk prostate cancer. Cancer causes & control : CCC. Apr 2014;25(4):515-523.', '26.', \"Gupta-Elera G, Garrett AR, Robison RA, O'Neill KL. The role of oxidative stress in prostate cancer. Eur\", 'J Cancer Prev. Mar 2012;21(2):155-162.', '27.', 'Gardner JR, Livingston PM, Fraser SF. Effects of exercise on treatment-related adverse effects for', 'patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. Journal of', 'clinical oncology : official journal of the American Society of Clinical Oncology. Feb 1 2014;32(4):335-', '346.', '28.', 'Baumann FT, Zopf EM, Bloch W. Clinical exercise interventions in prostate cancer patients--a', 'systematic review of randomized controlled trials. Support Care Cancer. Feb 2012;20(2):221-233', '29.', 'Keogh JW, MacLeod RD. Body composition, physical fitness, functional performance, quality of life,', 'and fatigue benefits of exercise for prostate cancer patients: a systematic review. Journal of pain and', 'symptom management. Jan 2012;43(1):96-110.', '30.', 'Galvao DA, Taaffe DR, Cormie P, et al. Efficacy and safety of a modular multi-modal exercise program', 'in prostate cancer patients with bone metastases: a randomized controlled trial. BMC Cancer.', '2011;11:517.', '31.', 'Galvao DA, Spry N, Denham J, et al. A multicentre year-long randomised controlled trial of exercise', 'training targeting physical functioning in men with prostate cancer previously treated with androgen', 'suppression and radiation from TROG 03.04 RADAR. European urology. May 2014;65(5):856-864.', '32.', 'Cormie P, Newton RU, Spry N, Joseph D, Taaffe DR, Galvao DA. Safety and efficacy of resistance', 'exercise in prostate cancer patients with bone metastases. Prostate Cancer Prostatic Dis. Dec', '2013;16(4):328-335.', '33.', 'Kirby M, Hirst C, Crawford ED. Characterising the castration-resistant prostate cancer population: a', 'systematic review. International journal of clinical practice. Nov 2011;65(11):1180-1192.', '34.', 'Resnick MJ, Penson DF. Quality of life with advanced metastatic prostate cancer. The Urologic clinics', 'of North America. Nov 2012;39(4):505-515.', '35.', 'Cormie P, Galvao DA, Spry N, Joseph D, Taaffe DR, Newton RU. Functional benefits are sustained', 'after a program of supervised resistance exercise in cancer patients with bone metastases: longitudinal', 'results of a pilot study. Supportive care in cancer : official journal of the Multinational Association of', 'Supportive Care in Cancer. Jun 2014;22(6):1537-1548.', '36.', 'Sathiakumar N, Delzell E, Morrisey MA, et al. Mortality following bone metastasis and skeletal-related', 'events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries,', '1999-2006. Prostate cancer and prostatic diseases. Jun 2011;14(2):177-183.', '37.', 'Scher HI, Halabi S, Tannock I, et al. Design and end points of clinical trials for patients with progressive', 'prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical', 'Trials Working Group. Journal of clinical oncology : official journal of the American Society of Clinical', 'Oncology. Mar 1 2008;26(7):1148-1159.', '38.', 'Monga U, Garber SL, Thornby J, et al. Exercise prevents fatigue and improves quality of life in prostate', 'cancer patients undergoing radiotherapy. Arch Phys Med Rehabil. Nov 2007;88(11):1416-1422', '39.', 'Segal RJ, Reid RD, Courneya KS, et al. Randomized controlled trial of resistance or aerobic exercise in', 'INTERVAL Protocol Version 4.0, 19 April 2018', '57']['men receiving radiation therapy for prostate cancer. J Clin Oncol. Jan 2009;27(3):344-351.', '40.', 'Hanson ED, Sheaff AK, Sood S, et al. Strength training induces muscle hypertrophy and functional', 'gains in black prostate cancer patients despite androgen deprivation therapy. The journals of', 'gerontology. Series A, Biological sciences and medical sciences. Apr 2013;68(4):490-498.', '41.', 'Buffart LM, Galvao DA, Chinapaw MJ, et al. Mediators of the resistance and aerobic exercise', 'intervention effect on physical and general health in men undergoing androgen deprivation therapy for', 'prostate cancer. Cancer. Jan 15 2014;120(2):294-301', '42.', 'Beer TM, Armstrong AJ, Rathkopf DE, et al. Enzalutamide in metastatic prostate cancer before', 'chemotherapy. The New England journal of medicine. Jul 31 2014;371(5):424-433.', '43.', 'Ryan CJ, Smith MR, Fizazi K, et al. Abiraterone acetate plus prednisone versus placebo plus', 'prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-', '302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.', 'The Lancet. Oncology. Feb 2015;16(2):152-160', '44.', 'Beer TM, Tombal B. Enzalutamide in metastatic prostate cancer before chemotherapy. The New', 'England journal of medicine. Oct 30 2014;371(18):1755-1756.', '45.', 'Ryan CJ, Smith MR, de Bono JS, et al. Abiraterone in metastatic prostate cancer without previous', 'chemotherapy. The New England journal of medicine. Jan 10 2013;368(2):138-148.', '46.', 'Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded', 'prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life', 'in men with prostate cancer. Urology. Dec 20 2000;56(6):899-905.', '47.', 'Praet SF, Jonkers RA, Schep G, et al. Long-standing, insulin-treated type 2 diabetes patients with', 'complications respond well to short-term resistance and interval exercise training. European journal of', 'endocrinology/ European Federation of Endocrine Societies. Feb 2008;158(2):163-172.', '48.', 'Hotamisligil GS. Inflammation and metabolic disorders. Nature. Dec 14 2006;444(7121):860-867', '49.', 'Vanderweele TJ, Vansteelandt S. Odds ratios for mediation analysis for a dichotomous outcome.', 'American journal of epidemiology. Dec 15 2010;172(12):1339-1348', '50.', 'VanderWeele TJ. Causal mediation analysis with survival data. Epidemiology. Jul 2011;22(4):582-585.', 'INTERVAL Protocol Version 4.0, 19 April 2018', '58']\n\n###\n\n", "completion": "END"}